SEC Form 4 · accession 0001759655-26-000057
Privia Health Group, Inc. · PRVA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Mountcastle
Officer — EVP & Chief Financial Officer
Period of report
Jul 9, 2026
Accepted (ET)
Jul 13, 2026 · 4:01 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001759655
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.01 per shareF2 | Jul 9, 2026 | S | 21,275 | $27.67 | D | 164,853 | D | |
| Common Stock, $0.01 par value per share | holding | — | — | — | 8,695 | I | By spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.50 to $27.80 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.